FDA’s Acceptance of AYVAKIT’s New Drug Application Offers Hope to Metastatic GIST Patients
source: pixabay.com

FDA’s Acceptance of AYVAKIT’s New Drug Application Offers Hope to Metastatic GIST Patients

  Surgery has been found to often be the best option towards a cure for a cancerous tumor (resectable) but there are many other tumors that are diagnosed as unresectable…

Continue Reading FDA’s Acceptance of AYVAKIT’s New Drug Application Offers Hope to Metastatic GIST Patients
New Partnership to Assess an Experimental Treatment for Sturge Weber Syndrome
source: pixabay.com

New Partnership to Assess an Experimental Treatment for Sturge Weber Syndrome

According to a story from Gurufocus, the precision medicines company IDEAYA Biosciences, Inc. and the Boston Children's Hospital have recently entered into a Sponsored Research Agreement. The arrangement will entail…

Continue Reading New Partnership to Assess an Experimental Treatment for Sturge Weber Syndrome
The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy
source: pixabay.com

The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy

According to an announcement from the Muscular Dystrophy Association, the organization has recently awarded a total of $1,076,232 in MDA Venture Philanthropy (MVP) funding towards the drug company AavantiBio, which…

Continue Reading The Muscular Dystrophy Association Awards Over $1M Towards Friedreich’s Ataxia Gene Therapy